These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39008816)

  • 1. Evolution of Health Technology Assessment in Indonesia: Supply Landscape, Implementation, and Future Directions.
    Hidayat B
    Health Syst Reform; 2023 Dec; 9(3):2371470. PubMed ID: 39008816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.
    Uzochukwu BSC; Okeke C; O'Brien N; Ruiz F; Sombie I; Hollingworth S
    Global Health; 2020 Jul; 16(1):58. PubMed ID: 32641066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply.
    Aryankhesal A; Behzadifar M; Bakhtiari A; Shahabi S; Azari S; Darvishi Teli B; Rezapour A; Ehsanzadeh SJ; Behzadifar M
    Health Res Policy Syst; 2024 Jan; 22(1):11. PubMed ID: 38225573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region.
    Sharma M; Teerawattananon Y; Dabak SV; Isaranuwatchai W; Pearce F; Pilasant S; Sabirin J; Mayxay M; Guerrero M; Phuong NK; Sastroasmoro S; Htoo TS
    Health Res Policy Syst; 2021 Feb; 19(1):19. PubMed ID: 33573676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.
    Tantivess S; Teerawattananon Y; Mills A
    Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of health technology assessment in China: New challenges.
    Chen Y; He Y; Chi X; Wei Y; Shi L
    Biosci Trends; 2018; 12(2):102-108. PubMed ID: 29760354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptake.
    Uzochukwu BSC; Okeke C; Shuaib F; Torres-Rueda S; Vassall A; Jit M; Nonvignon J; Uzochukwu AC; Ruiz F
    Health Res Policy Syst; 2024 Jun; 22(1):73. PubMed ID: 38926716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institutionalizing Health Technology Assessment in South Africa-An Opportunity in National Health Insurance.
    Jugathpal J; Parrish A; Jamaloodien K; Blecher M; Daven J
    Health Syst Reform; 2023 Dec; 9(3):2327098. PubMed ID: 38715202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing institutionalization of health technology assessment in Kenya.
    Mbau R; Vassall A; Gilson L; Barasa E
    BMC Health Serv Res; 2023 Jun; 23(1):681. PubMed ID: 37349812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health technology assessment for radiologists: basic principles and evaluation framework.
    Lim ME; O'Reilly D; Tarride JE; Burke N; Ferrusi IL; Campbell K; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):299-306. PubMed ID: 19394570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India.
    Dabak SV; Pilasant S; Mehndiratta A; Downey LE; Cluzeau F; Chalkidou K; Luz ACG; Youngkong S; Teerawattananon Y
    Health Res Policy Syst; 2018 Nov; 16(1):115. PubMed ID: 30486827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.
    Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S
    Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA.
    Pichon-Riviere A; Soto N; Augustovski F; Sampietro-Colom L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):248-253. PubMed ID: 29888698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health technology assessment and primary data collection for reducing uncertainty in decision making.
    Goeree R; Levin L; Chandra K; Bowen JM; Blackhouse G; Tarride JE; Burke N; Bischof M; Xie F; O'Reilly D
    J Am Coll Radiol; 2009 May; 6(5):332-42. PubMed ID: 19394574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Institutionalizing Evidence-Informed Priority Setting for Universal Health Coverage: Lessons From Indonesia.
    Sharma M; Teerawattananon Y; Luz A; Li R; Rattanavipapong W; Dabak S
    Inquiry; 2020; 57():46958020924920. PubMed ID: 32513029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A situational and stakeholder analysis of health technology assessment in Zimbabwe.
    Dzingirai B; Dambiko P; Matyanga C; Manyau P; Tagwireyi D; Postma MJ; Mafirakureva N; van Hulst M
    Int J Technol Assess Health Care; 2024 Apr; 40(1):e27. PubMed ID: 38679461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Institutionalizing Health Technology Assessment in Ghana: Enablers, Constraints, and Lessons.
    Koduah A; Anim Boadi J; Azeez JNK; Adu Asare B; Yevutsey S; Gyansa-Lutterodt M; Nonvignon J
    Health Syst Reform; 2023 Dec; 9(3):2314519. PubMed ID: 38715200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Landscape analysis of health technology assessment (HTA): systems and practices in Asia.
    Teerawattananon Y; Rattanavipapong W; Lin LW; Dabak SV; Gibbons B; Isaranuwatchai W; Toh KY; Cher BP; Pearce F; Bayani DBS; Nakamura R; Pwu RF; Shafie AA; Adhikari D; Prinja S; Babidge W
    Int J Technol Assess Health Care; 2019; 35(6):416-421. PubMed ID: 31594553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders.
    Wasir R; Irawati S; Makady A; Postma M; Goettsch W; Feenstra T; Buskens E
    PLoS One; 2019; 14(11):e0225626. PubMed ID: 31774854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.